Murad files lawsuit against Strawberry.net
This article was originally published in The Rose Sheet
Executive Summary
Dermatologist-developed skin-care firm has filed a U.S. federal court lawsuit against the owners and operators of Strawberrynet.com, a Hong Kong-based website, for diverting and selling defaced Murad products, the El Segundo, Calif.-based company announces June 3. Strawberry.net, which has no authorized relationship with Murad, is selling more than 80 products from nine of the company's lines, as of the filing date of the suit. In its filing, the firm alleges that the Murad products sold on the site have been defaced and stripped of quality-control tracking features including hologram protection seals and unique batch codes used for tracking and protecting the public from counterfeit goods and health risks. Murad is sold through retailers worldwide including Sephora, Ulta and Massage Envy, as well as at numerous spas and salons
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.